stockrowLeMaitre Vascular, Inc.
LMAT Healthcare Medical Instruments & Supplies
LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.
- Revenue
- +11.3%
- EPS
- −14.3%
- Free cash flow
- −25.8%
- Total debt
- +0.53%
Quarter to September 2026, against a year earlier
Follow LMAT
Alert me
LeMaitre Vascular, Inc. (LMAT) Revenue growth
LeMaitre Vascular, Inc.'s revenue growth over the twelve months to 30 September 2026 was 11.8%, down 1.7 percentage points from fiscal 2025 (13.5%). Over the past ten years it has ranged from 4.66% (fiscal 2018) to 19.7% (fiscal 2023); the current reading is higher than 64% of that period. That is above the Medical Instruments & Supplies industry median of 8.97% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 13.5% | (0.10) |
| FY2024 | 13.6% | (6.06) |
| FY2023 | 19.7% | 15.01 |
| FY2022 | 4.68% | (14.69) |
| FY2021 | 19.4% | 9.02 |
| FY2020 | 10.4% | (0.70) |
| FY2019 | 11.1% | 6.39 |
| FY2018 | 4.66% | (8.48) |
| FY2017 | 13.1% | (0.64) |
| FY2016 | 13.8% | 3.58 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 11.3% | 1.77 |
| Jun 2026 | 9.57% | (1.59) |
| Mar 2026 | 11.2% | (4.52) |
| Dec 2025 | 15.7% | 4.32 |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PLSE Pulse Biosciences, Inc compare | 90.1% |
| KMTS Kestra Medical Technologies, Ltd. compare | 60.7% |
| STAA STAAR Surgical Company compare | 42.4% |
| ATRC AtriCure, Inc. compare | 13.8% |
| LMAT LeMaitre Vascular, Inc. | 11.8% |
| STVN Stevanato Group S.p.A. compare | 11.6% |
| WRBY Warby Parker Inc. compare | 9.89% |
| AZTA Azenta, Inc. compare | 4.80% |
| XRAY DENTSPLY SIRONA Inc. compare | −1.35% |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on LMAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement